This is the authors' abstract. We don't add key points for this paper.
Epstein-Barr virus (EBV) is one of eight known herpesviruses with the potential to infect humans. Globally, it is estimated that between 90-95% of the population has been infected with EBV. EBV is an oncogenic virus that has been strongly linked to various epithelial malignancies such as nasopharyngeal and gastric cancer. Recent evidence suggests a link between EBV and breast cancer. Additionally, there are other, rarer cancers with weaker evidence linking them to EBV. In this review, we discuss the currently known epithelial malignancies associated with EBV. Additionally, we discuss and establish which treatments and therapies are most recommended for each cancer associated with EBV.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shechter et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: